May 3, 2018 / 10:43 AM / 3 months ago

BRIEF-Sage Therapeutics Reports Quarterly Loss Per Share Of $1.68

May 3 (Reuters) - SAGE Therapeutics Inc:

* SAGE THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES UPDATE ON PIPELINE AND PROGRESS TOWARD LAUNCH READINESS

* QUARTERLY LOSS PER SHARE $1.68

* SAGE THERAPEUTICS - ANTICIPATES EXISTING CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES TO FUND OPERATING EXPENSES, CAPEX REQUIREMENTS INTO 2020

* EXPECTS THAT OPERATING EXPENSES WILL INCREASE YEAR OVER YEAR IN 2018

* Q1 EARNINGS PER SHARE VIEW $-1.84 — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below